This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
CADTH. Neurofeedback and biofeedback for post-traumatic stress disorder, generalized anxiety disorder, and depression: a review of the clinical evidence and guidelines.
. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). 2012
Evidence from mostly preliminary analyses raised the possibility that biofeedback and neurofeedback may have a potential for the treatment of post-traumatic stress disorder, generalized anxiety disorder, or depression. No relevant evidence-based guidelines were identified.
Subject indexing assigned by CRD
Anxiety Disorders; Biofeedback, Psychology; Depressive Disorder; Neurofeedback; Stress Disorders, Post-Traumatics
Country of organisation
An English language summary is available.
Address for correspondence
Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, K1S 5S8 Ottawa, Ontario Canada Email: firstname.lastname@example.org
Date abstract record published